Search results
Novo Nordisk faces scrutiny on Capitol Hill for pulling Levemir insulin from US market - ET...
The Economic Times· 24 hours agoLondon: Democratic U.S. Senate aides will meet with Novo Nordisk executives on Tuesday to discuss fallout from its decision to stop selling one of its long-acting insulins in the country, two ...